Literature DB >> 25838203

cCMP and cUMP occur in vivo.

Heike Bähre1, Christina Hartwig2, Antje Munder3, Sabine Wolter4, Tane Stelzer5, Bastian Schirmer6, Ulrike Beckert7, Dara W Frank8, Burkhard Tümmler9, Volkhard Kaever10, Roland Seifert11.   

Abstract

Mammalian cells contain the cyclic pyrimidine nucleotides cCMP and cUMP. It is unknown whether these tentative new second messenger molecules occur in vivo. We used high performance liquid chromatography quadrupole tandem mass spectrometry to quantitate nucleoside 3',5'-cyclic monophosphates. cCMP was detected in all organs studied, most notably pancreas, spleen and the female reproductive system. cUMP was not detected in organs, probably due to the intrinsically low sensitivity of mass spectrometry to detect this molecule and organ matrix effects. Intratracheal infection of mice with recombinant Pseudomonas aeruginosa harboring the nucleotidyl cyclase toxin ExoY massively increased cUMP in lung. The identity of cCMP and cUMP in organs was confirmed by high performance liquid chromatography quadrupole time of flight mass spectrometry. cUMP also appeared in serum, urine and faeces following infection. Taken together, this report unequivocally shows for the first time that cCMP and cUMP occur in vivo.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclic pyrimidine nucleotides; ExoY; Mass spectrometry; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2015        PMID: 25838203      PMCID: PMC4765920          DOI: 10.1016/j.bbrc.2015.03.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  The "soluble" adenylyl cyclase in sperm mediates multiple signaling events required for fertilization.

Authors:  Kenneth C Hess; Brian H Jones; Becky Marquez; Yanqiu Chen; Teri S Ord; Margarita Kamenetsky; Catarina Miyamoto; Jonathan H Zippin; Gregory S Kopf; Susan S Suarez; Lonny R Levin; Carmen J Williams; Jochen Buck; Stuart B Moss
Journal:  Dev Cell       Date:  2005-08       Impact factor: 12.270

2.  Soluble adenylyl cyclase accounts for high basal cCMP and cUMP concentrations in HEK293 and B103 cells.

Authors:  Alan Hasan; Kerstin Y Danker; Sabine Wolter; Heike Bähre; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2014-04-30       Impact factor: 3.575

3.  Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.

Authors:  Heike Bähre; Kerstin Y Danker; Johannes-Peter Stasch; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2013-12-28       Impact factor: 3.575

4.  Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.

Authors:  Joel Castro; Andrea M Harrington; Patrick A Hughes; Christopher M Martin; Pei Ge; Courtney M Shea; Hong Jin; Sarah Jacobson; Gerhard Hannig; Elizabeth Mann; Mitchell B Cohen; James E MacDougall; Bernard J Lavins; Caroline B Kurtz; Inmaculada Silos-Santiago; Jeffrey M Johnston; Mark G Currie; L Ashley Blackshaw; Stuart M Brierley
Journal:  Gastroenterology       Date:  2013-08-16       Impact factor: 22.682

5.  Assessing Pseudomonas virulence using mammalian models: acute infection model.

Authors:  Antje Munder; Burkhard Tümmler
Journal:  Methods Mol Biol       Date:  2014

Review 6.  Pulmonary hypertension: novel pathways and emerging therapies inhibitors of cGMP and cAMP metabolism.

Authors:  Yassine Sassi; Jean-Sébastien Hulot
Journal:  Handb Exp Pharmacol       Date:  2013

7.  cCMP is a substrate for MRP5.

Authors:  Svenja Laue; Moritz Winterhoff; Volkhard Kaever; Jeroen J van den Heuvel; Frans G Russel; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

8.  ExoY from Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for cGMP and cUMP formation.

Authors:  Urike Beckert; Sabine Wolter; Christina Hartwig; Heike Bähre; Volkhard Kaever; Daniel Ladant; Dara W Frank; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2014-06-24       Impact factor: 3.575

9.  The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury.

Authors:  Trevor C Stevens; Cristhiaan D Ochoa; K Adam Morrow; Matthew J Robson; Nutan Prasain; Chun Zhou; Diego F Alvarez; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-04       Impact factor: 5.464

10.  Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor.

Authors:  Kerstin Y Beste; Corinna M Spangler; Heike Burhenne; Karl-Wilhelm Koch; Yuequan Shen; Wei-Jen Tang; Volkhard Kaever; Roland Seifert
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more
  15 in total

Review 1.  The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

Authors:  K Adam Morrow; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Handb Exp Pharmacol       Date:  2017

2.  cUMP hydrolysis by PDE3A.

Authors:  Stefan Berrisch; Jessica Ostermeyer; Volkhard Kaever; Solveig Kälble; Denise Hilfiker-Kleiner; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

3.  Recent progress in the field of cIMP research.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-18       Impact factor: 3.000

4.  cUMP hydrolysis by PDE3B.

Authors:  Jessica Ostermeyer; Franziska Golly; Volkhard Kaever; Stefan Dove; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

5.  Bacterial Nucleotidyl Cyclase Inhibits the Host Innate Immune Response by Suppressing TAK1 Activation.

Authors:  Chenxi He; Yilong Zhou; Feng Liu; Haipeng Liu; Hao Tan; Shouguang Jin; Weihui Wu; Baoxue Ge
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

6.  Cyclic CMP and cyclic UMP mediate bacterial immunity against phages.

Authors:  Nitzan Tal; Benjamin R Morehouse; Adi Millman; Avigail Stokar-Avihail; Carmel Avraham; Taya Fedorenko; Erez Yirmiya; Ehud Herbst; Alexander Brandis; Tevie Mehlman; Yaara Oppenheimer-Shaanan; Alexander F A Keszei; Sichen Shao; Gil Amitai; Philip J Kranzusch; Rotem Sorek
Journal:  Cell       Date:  2021-10-12       Impact factor: 66.850

7.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

8.  Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode.

Authors:  Jessica Scharrenbroich; Volkhard Kaever; Stefan Dove; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-15       Impact factor: 3.000

9.  Extracellular vesicles: another compartment for the second messenger, cyclic adenosine monophosphate.

Authors:  Sarah L Sayner; Chung-Sik Choi; Marcy E Maulucci; K C Ramila; Chun Zhou; April K Scruggs; Thomas Yarbrough; Leslie A Blair; Judy A King; Roland Seifert; Volkhard Kaever; Natalie N Bauer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-13       Impact factor: 6.011

Review 10.  Cross Kingdom Activators of Five Classes of Bacterial Effectors.

Authors:  David M Anderson; Jimmy B Feix; Dara W Frank
Journal:  PLoS Pathog       Date:  2015-07-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.